Lloyd C. Miller (1907-1998) contributed significantly to the public health of Americans during his 50 years of service to the United States Pharmacopeia (USP), and the U.S. Food and Drug Administration (FDA). Dr. Miller was engaged in both regulatory work and research on drug assays, publishing the digitalis biologic assay for which he was awarded the Ebert Prize by the American Pharmaceutical Association in 1939.
Before joining USP as a staff member, Miller was a research scientist with the Food and Drug Administration from 1935-1943, and served as a member of the USP Committee of Revision in the 1940's. In 1950 Miller became USP's first full-time salaried employee, serving as Director of Revision for twenty years. He was actively associated with the International Pharmacopeia of the World Health Organization from 1951-1970, and was a founding member of the AMA—USP Nomenclature Committee in 1961. He served continuously on the USP Nomenclature Committee and its successor the U.S. Adopted Names Council until 1986.
Dr. Miller earned degrees from Pomona College, B.A. and the University of Rochester School of Medicine and Dentistry, Ph.D. In addition, he received an honorary degree of Sc.D from the Philadelphia College of Pharmacy and Science.
Published Oct 7, 2010
